Transplantation Clinical Trials

340 recruitingLast updated: June 18, 2026

There are 340 actively recruiting transplantation clinical trials across 39 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Houston, Texas, United States, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Transplantation Trials at a Glance

340 actively recruiting trials for transplantation are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 106 trials, with the heaviest enrollment activity in Houston, New York, and Boston. Lead sponsors running transplantation studies include The First Affiliated Hospital of Soochow University, Assistance Publique - Hôpitaux de Paris, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse transplantation trials by phase

Treatments under study

About Transplantation Clinical Trials

Looking for clinical trials for Transplantation? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transplantation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 340 trials

Recruiting
Phase 4

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Acute Kidney InjuryLiver Transplantation
Rennes University Hospital400 enrolled8 locationsNCT06535945
Recruiting
Not Applicable

Rectus-Intercostal Fascial Plane Block for Liver Transplantation Donors

Postoperative PainLiver TransplantationLiving Donor
Istinye University64 enrolled1 locationNCT07233096
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting
Phase 2

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati60 enrolled1 locationNCT05501756
Recruiting
Phase 1Phase 2

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)260 enrolled2 locationsNCT05436418
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting
Not Applicable

A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients

Hair TransplantationScalp CareSeborrheic Dermatitis
ChinaNorm120 enrolled1 locationNCT07641686
Recruiting
Not Applicable

The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

Renal Transplantation
Akdeniz University56 enrolled1 locationNCT07294183
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Early Phase 1

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation
Case Comprehensive Cancer Center20 enrolled1 locationNCT04332341
Recruiting
Not Applicable

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation
National Cancer Institute (NCI)222 enrolled2 locationsNCT05605574
Recruiting

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationTissue Donors
National Cancer Institute (NCI)2,000 enrolled1 locationNCT03000244
Recruiting
Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

LymphomaLeukemiaCAR-T Cell Therapy+3 more
University of Arizona200 enrolled1 locationNCT06643221
Recruiting
Early Phase 1

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Mari Dallas20 enrolled1 locationNCT03378102
Recruiting
Phase 1Phase 2

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Kidney TransplantationKidney Failure, ChronicAlloimmunization+3 more
Hospital Universitari Vall d'Hebron Research Institute10 enrolled1 locationNCT07607197
Recruiting
Phase 1Phase 2

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Sickle Cell DiseaseGraft FailureHematopoetic Stem Cell Transplant+2 more
Arkansas Children's Hospital Research Institute24 enrolled4 locationsNCT07252050
Recruiting

Trifecta-Lung cfDNA-MMDx Study

Lung transplantation
University of Alberta600 enrolled19 locationsNCT05837663
Recruiting
Not Applicable

Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients

Liver TransplantLiver Transplant SurgeryLiver Transplantation+1 more
Medical University of Warsaw434 enrolled1 locationNCT07519057
Recruiting
Not Applicable

Pilates Exercises on Balance, Fatigue and Quality of Life

Renal Transplantation
Cairo University50 enrolled2 locationsNCT07626086
Recruiting

Genome Transplant Dynamics

Thoracic Organ Transplantation
National Heart, Lung, and Blood Institute (NHLBI)991 enrolled6 locationsNCT02423070